We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Novel 3D Growth Chamber Designed for Investigating Effects of Electric Fields on Cancer

By LabMedica International staff writers
Posted on 19 Jul 2016
Print article
Image: Three microfluidic devices filled with food color dyes. The device, about the size of a credit card, is designed for the 3D growth of breast, lung, and other types of cancer cells while being exposed to an electric field (Photo courtesy of the Massachusetts Institute of Technology).
Image: Three microfluidic devices filled with food color dyes. The device, about the size of a credit card, is designed for the 3D growth of breast, lung, and other types of cancer cells while being exposed to an electric field (Photo courtesy of the Massachusetts Institute of Technology).
A team of bioengineers designed and manufactured a novel microfluidic device for use in studying the effects of an electric field on the growth and spread of cancer cells.

A promising alternative approach to cancer therapy is based on exposing the tumor to an alternating electric field. The current study describes a device designed to facilitate research for understanding the mechanisms involved in the disruption of the cancer cell cycle by the electric field as well as any potential adverse effects on non-cancerous cells.

Investigators at The Singapore-MIT Alliance for Research and Technology (SMART) (Singapore) engineered a microfluidic device with embedded contactless electrodes to culture cells in the presence of an alternating electric field in a highly controlled microenvironment.

The device was fabricated from PDMS (polydimethylsiloxane), and a pattern of small channels was inscribed across its surface. A conductive mixture was prepared from micron-sized silver flakes and PDMS, and the mixture was injected into separate channels in the device to form two separate electrodes. In the region between the electrodes, it was possible to inject hydrogels - which created a three-dimensional microenvironment - containing healthy human endothelial cells or breast or lung cancer cells as well as small tumor masses. Cells growing in the three-dimensional matrix were exposed to alternating electric fields at frequencies of 150 or 200 kilohertz, continuously, at an intensity of 1.1 volts per centimeter.

To demonstrate the potential of the system for aiding in the design and testing of new therapeutic approaches, cancer cells and cancer cell aggregates were cultured individually in the device or were co-cultured with endothelial cells.

Results published in the May 24, 2016, online edition of the journal Scientific Reports revealed that the metastatic potential of the cancer cells was reduced after electric field treatment. Moreover, the proliferation rate of the treated cancer cells was lower compared with that of untreated cells, while the morphologies and proliferative capacities of the endothelial cells were not significantly affected.

“We hope this device will increase interest by researchers who are exploring the effect of electric fields on different types of cancer,” said contributing author Dr. Giulia Adriani, a research scientist at SMART. “In our study, we noticed the effect was limited to the cancer cell at the tested frequencies and intensities, but we really need to explore other cells and parameters. For personalized medicine, you can test if a recipe works for a specific person. In three days, you can have an answer. And for many cancer patients who are dying of metastasis, time is everything.”

Related Links:
Singapore-MIT Alliance for Research and Technology


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Reagent Reservoirs
Reagent Reservoirs

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.